Virtu KCG Holdings’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-36,199
Closed -$16K 4292
2015
Q3
$16K Sell
36,199
-162,612
-82% -$93K ﹤0.01% 3191
2015
Q2
$99K Buy
198,811
+182,135
+1,092% +$124K ﹤0.01% 2916
2015
Q1
$12K Sell
16,676
-144,681
-90% -$92.9K ﹤0.01% 3004
2014
Q4
$86K Buy
161,357
+128,130
+386% +$77.5K ﹤0.01% 3280
2014
Q3
$19K Buy
+33,227
New +$42.1K ﹤0.01% 3480
2014
Q2
Sell
-20,025
Closed -$36K 4361
2014
Q1
$36K Sell
20,025
-6,847
-25% -$11.6K ﹤0.01% 3382
2013
Q4
$42K Buy
26,872
+13,611
+103% +$30.7K ﹤0.01% 3636
2013
Q3
$32K Buy
+13,261
New +$36.7K ﹤0.01% 3569

Other funds holding ONCY

Virtu KCG Holdings's ONCY Position: Q4 2015 in Review

Virtu KCG Holdings sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 36,199 shares — an estimated $16K sold.

Virtu KCG Holdings first reported a position in ONCY in Q3 2013 and held it in 8 quarters. The position peaked at $99K in Q2 2015. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • Virtu KCG Holdings reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • Virtu KCG Holdings sold 36,199 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $16K.
  • Virtu KCG Holdings first reported a position in ONCOLYTICS BIOTECH INC in Q3 2013 and held it in 8 quarters.
  • Virtu KCG Holdings's ONCOLYTICS BIOTECH INC position peaked at $99K in Q2 2015.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Virtu KCG Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.